Cancer Flashcards
Bcl2
Oncogene
Anti-apoptosis protein
BCR and ABL
Oncogene
fused in chronic myeloid leukaemias
ABL is a tyr kinase
Reciprocal translocation between chromosomes 9 and 22
Forms the smaller Philadelphia chromosome
Beta-catenin
Oncogene
Interacts with APC and mutated in small % colon cancers
Wnt signalling pathway
BRAF
Oncogene
Downstream of Ras, mutated in melanomas and other tumours and activated by other mechanisms including fusion
V600E activation
Val –> glutamic acid
Adjacent to an activating phosphorylation site
Negative charge of glutamic acid mimics phosphorylation and so activates
CCND1/CyclinD1
Oncogene
Activated by amplification in breast cancer
Controls Rb1 with CDK4
EGFR/ERBB
ERBB2/HER2
Oncogenes
The ERBB family of RTKs includes ERBB aka EGF-receptor and ERBB2 aka HER2 - the target of breast cancer drug Herceptin
ERG and TMPRSS2-ERG fusion
Oncogene
ERG is a TF involved in gene fusions in prostate cancers, leukaemias etc. TMPRSS2-ERG in 1/2 prostate cancers
Controls differentiation
MLL
Oncogene
Histone methyltransferase, modifies histones, fused by translocation in leukaemias
MYC family
Oncogene
TFs, clearly powerful and widely abnormal oncogenes (can be amplified), function unclear
Powerfully upreg many genes involved in proliferation, widely activated
PIK3CA
Oncogene
Subunit of PI3Kinase, mutated in 1/3 breast, colorectal etc
Point mutated - one particularly common mutation changes a particularly -ve aa to +vely charged one
Ras family, including KRAS
Oncogene
G proteins that carry signals from growth factor receptors to nucleus, activating the MAPkinase pathway. All become oncogenes when point mutated to active form in the same way
Blocks GTP hydrolysis, some by preventing access of GTP-ase activating proteins that complete the active site
APC
Tumour suppressor gene
Large cytoplasmic protein that interacts with beta-catenin, component of the Wnt signalling pathway. Inactivated in most colon carcinomas. Inherited mutation gives polyposis coli
Normally indels
BRCA1 and BRCA2
Tumour suppressor gene
Mutated in some families with strong hereditary predisposition to breast cancer. Component of homologous recombination DNA ds break repair. Protein unrelated to BRCA1 or 2.
CDKN2A/INK4a/p16
Tumour suppressor gene
Inhibitor of Cdks, often deleted
MLH1, MSH2
Tumour suppressor gene
Recognition proteins of the mismatch repair complex, mutated in some non-hereditary colon cancers and Lynch Syndrome families. MLH1 is an example of a gene frequently inactivated by DNA methylation of its promoter.
p53
Tumour suppressor gen
Nuclear protein that arrests cell cycle in response to DNA damage and other insults. Mutated in 30-50% cancers
PTEN
Tumour suppressor gene
Phosphatase that antagonises PI3KCA
Suffers inactivating point mutatiosn or deletions
Rb-1
Tumour suppressor gene
Nuclear protein that regulates cell cycle. Discovered in retinoblastoma but also mutated in other human tumours
Smad4
Tumour suppressor gene
Carries inhibitory signals in TGF-beta pathway. Mutated in some colon carcinomas and other cancers
TGF-beta family
Tumour suppressor gene
Often inhibitory growth factors that regulate the differentiation of cells.
Define cancer
A disease caused by alteration of a cell’s genes resulting in a failure of 3D growth and tissue repair
Which gene changes can result in cancer?
Mutations
Epigenetic change including DNA methylation or histone modification
Tumour viruses bringing extra genes into a cell
Define metastasis
Formation of new colonies of tumour in other parts of the body by the seeding of cells into the blood or lymphatics
Define a benign tumour
Tumours incapable of metastasis unless subsequent metastasis turns them into a malignant tumour